HEX
Server: Apache
System: Linux zacp120.webway.host 4.18.0-553.50.1.lve.el8.x86_64 #1 SMP Thu Apr 17 19:10:24 UTC 2025 x86_64
User: govancoz (1003)
PHP: 8.3.26
Disabled: exec,system,passthru,shell_exec,proc_close,proc_open,dl,popen,show_source,posix_kill,posix_mkfifo,posix_getpwuid,posix_setpgid,posix_setsid,posix_setuid,posix_setgid,posix_seteuid,posix_setegid,posix_uname
Upload Files
File: /home/govancoz/mail/.spam/new/1717681227.M240800P2754909.zacp120.ve.host,S=6203,W=6319
Return-Path: <tony41@qc.commufa.jp>
Delivered-To: govancoz+spam@zacp120.ve.host
Received: from zacp120.ve.host
	by zacp120.ve.host with LMTP
	id qCYkDUu8YWZdCSoAvcbEzQ
	(envelope-from <tony41@qc.commufa.jp>)
	for <govancoz+spam@zacp120.ve.host>; Thu, 06 Jun 2024 15:40:27 +0200
Return-path: <tony41@qc.commufa.jp>
Envelope-to: cheryl@govan.co.za
Delivery-date: Thu, 06 Jun 2024 15:40:27 +0200
Received: from busy-vaughan.212-227-32-35.plesk.page ([212.227.32.35]:55414)
	by zacp120.ve.host with esmtps  (TLS1.3) tls TLS_AES_256_GCM_SHA384
	(Exim 4.97.1)
	(envelope-from <tony41@qc.commufa.jp>)
	id 1sFDLw-0000000Bb7r-1rhe
	for cheryl@govan.co.za;
	Thu, 06 Jun 2024 15:40:27 +0200
Received: from busy-vaughan.212-227-32-35.plesk.page (localhost.localdomain [127.0.0.1])
	by busy-vaughan.212-227-32-35.plesk.page (Postfix) with ESMTP id DC2571CAF222;
	Thu,  6 Jun 2024 04:46:20 +0200 (CEST)
Authentication-Results: busy-vaughan.212-227-32-35.plesk.page;
        spf=pass (sender IP is 127.0.0.1) smtp.mailfrom=tony41@qc.commufa.jp smtp.helo=busy-vaughan.212-227-32-35.plesk.page
Received-SPF: pass (busy-vaughan.212-227-32-35.plesk.page: localhost is always allowed.) client-ip=127.0.0.1; envelope-from=tony41@qc.commufa.jp; helo=busy-vaughan.212-227-32-35.plesk.page;
X-Spam-Level: 
Received: from busy-vaughan.212-227-32-35.plesk.page ([127.0.0.1])
 by busy-vaughan.212-227-32-35.plesk.page (busy-vaughan.212-227-32-35.plesk.page [127.0.0.1]) (amavisd-new, port 10024)
 with ESMTP id Lpzw6rn4ZHiZ; Thu,  6 Jun 2024 04:46:19 +0200 (CEST)
Received: from [192.168.1.17] (unknown [197.232.126.205])
	by busy-vaughan.212-227-32-35.plesk.page (Postfix) with ESMTPA id D9B891999813;
	Thu,  6 Jun 2024 04:32:25 +0200 (CEST)
Received-SPF: pass (busy-vaughan.212-227-32-35.plesk.page: connection is authenticated)
Content-Type: multipart/alternative; boundary="===============1768626666=="
MIME-Version: 1.0
To: Recipients <tony41@qc.commufa.jp>
From: "Dr. Yasunobu Otsuga" <tony41@qc.commufa.jp>
Date: Thu, 06 Jun 2024 05:32:14 +0300
Reply-To: dr.yotsugadaito@gmail.com
X-Spam-Status: Yes, score=7.4
X-Spam-Score: 74
X-Spam-Bar: +++++++
X-Spam-Report: Spam detection software, running on the system "zacp120.ve.host",
 has identified this incoming email as possible spam.  The original
 message has been attached to this so you can view it or label
 similar future email.  If you have any questions, see
 root\@localhost for details.
 Content preview:  Hello I'm Dr. Yasunobu Otsuga, CEO of Daito Pharmaceutical,
    a leading company based in Japan. Currently, we're in search of a qualified
    individual to serve as our representative in South Africa for mi [...] 
 Content analysis details:   (7.4 points, 5.0 required)
  pts rule name              description
 ---- ---------------------- --------------------------------------------------
  0.5 SUBJ_ALL_CAPS          Subject is all capitals
  1.5 SPF_SOFTFAIL           SPF: sender does not match SPF record (softfail)
  0.0 HTML_MESSAGE           BODY: HTML included in message
  0.0 RCVD_IN_VALIDITY_CERTIFIED_BLOCKED RBL: ADMINISTRATOR NOTICE:
                             The query to Validity was blocked.  See
                             https://knowledge.validity.com/hc/en-us/articles/20961730681243
                              for more information.
                             [212.227.32.35 listed in sa-accredit.habeas.com]
  0.0 RCVD_IN_VALIDITY_RPBL_BLOCKED RBL: ADMINISTRATOR NOTICE: The
                             query to Validity was blocked.  See
                             https://knowledge.validity.com/hc/en-us/articles/20961730681243
                              for more information.
                             [212.227.32.35 listed in bl.score.senderscore.com]
 -0.0 T_SCC_BODY_TEXT_LINE   No description available.
  0.0 KAM_DMARC_STATUS       Test Rule for DKIM or SPF Failure with Strict
                             Alignment
  2.6 RDNS_DYNAMIC           Delivered to internal network by host with
                             dynamic-looking rDNS
  0.2 KAM_DMARC_NONE         DKIM has Failed or SPF has failed on the message
                             and the domain has no DMARC policy
  2.5 FREEMAIL_FORGED_REPLYTO Freemail in Reply-To, but not From
X-Spam-Flag: YES
Subject:  ***SPAM***  PROPOSED PARTNERSHIP.

You will not see this in a MIME-aware mail reader.
--===============1768626666==
Content-Type: text/plain; charset="iso-8859-1"
MIME-Version: 1.0
Content-Transfer-Encoding: quoted-printable
Content-Description: Mail message body

Hello
 I'm Dr. Yasunobu Otsuga, CEO of Daito Pharmaceutical, a leading company ba=
sed in Japan. Currently, we're in search of a qualified individual to serve=
 as our representative in South Africa for mineral procurement and to spear=
head the establishment of our annex office in the Republic of South Africa.=
 This endeavor, spanning a five-year contract, is pivotal in our strategic =
plan to expand our operations and fortify our presence in the South African=
 market. If this opportunity intrigues you, please respond, and we'll provi=
de further details. =

 Best  regards,
Dr. Yasunobu Otsuga
President & CEO
Daito Pharmaceutical Co., Ltd

--===============1768626666==
Content-Type: text/html; charset="iso-8859-1"
MIME-Version: 1.0
Content-Transfer-Encoding: quoted-printable
Content-Description: Mail message body

<HTML><head><meta http-equiv=3D"Content-Type" content=3D"text/html; charset=
=3Diso-8859-1"/></head><BODY><P>Hello</P>
<P>I'm Dr. Yasunobu Otsuga, CEO of Daito Pharmaceutical, a leading company =
based in Japan. Currently, we're in search of a qualified individual to ser=
ve as our representative in South Africa for mineral procurement and to spe=
arhead the establishment of our annex office in the Republic of South Afric=
a. This endeavor, spanning a five-year contract, is pivotal in our strategi=
c plan to expand our operations and fortify our presence in the South Afric=
an market. If this opportunity intrigues you, please respond, and we'll pro=
vide further details. </P>
<P>Best&nbsp; regards,<BR>Dr. Yasunobu Otsuga<BR>President &amp; CEO<BR>Dai=
to Pharmaceutical Co., Ltd</P></BODY></HTML>
--===============1768626666==--